Biography:
Dr. Feng has been engaged in clinical research on malignant tumors since 2009. Her major achievements include a randomized prospective cohort study on the prophylactic use of antiviral drugs in HBV carriers during chemotherapy, as well as a study on the high-risk factors of local recurrence after breast-conserving surgery in HER-2 positive breast cancer. Dr. Feng received her Ph.D. degree in 2018 with a focus on tumor biology and drug development. In 2019, Dr. Feng was appointed as the Vice-Chairman of the Clinical Oncology Nutrition and Metabolism Branch of the Shenzhen Anti-Cancer Association.
Title : Develop the overall diagnosis and treatment strategy of infectious disease epidemic and create a novel precise diagnosis and treatment model of cytokine storm
Title : To develop an overall diagnosis and treatment strategy to the epidemic situation of infectious diseases and establish an innovative medical model for precise diagnosis and treatment of cytokine storm